Ticker: CABA

Company: Cabaletta Bio, Inc.

Person: Mark Simon, director

Transaction date: Jan. 21, 2026

Reporting date: Jan. 21, 2026

Average share price: 2.2838

Bought 11061.0 shares for 25261.11